Balfour Beatty PLC
11 April 2006
DIRECTOR/PDMR SHAREHOLDING
--------------------------
Name of issuer:
Balfour Beatty plc
Names of individuals:
James Lionel Cohen (director)
Anthony Leon Philip Rabin (director)
Ian Paul Tyler (director)
Peter John Louis Zinkin (director)
Brian Osborne (PDMR)
Michael John Peasland (PDMR)
Andrew Edward Rose (PDMR)
Description of the financial instrument:
Ordinary shares
Nature of the transaction:
Awards of shares under the Company's Deferred Bonus Scheme 2006 ('Scheme'), to
be transferred to individuals for nil consideration in three years time subject
to the rules of the Scheme
Date and place of transaction:
10 April 2006
Date of notification of the transaction:
10 April 2006
Price and volume of the transaction (numbers of shares awarded):
J L Cohen 13,155 shares
A L P Rabin 13,573 shares
I P Tyler 19,629 shares
P J L Zinkin 14,116 shares
B Osborne 10,524 shares
M J Peasland 14,520 shares
A E Rose 11,447 shares
Notification is made under s 324 Companies Act 1985 and under Disclosure Rule
3.1.2.
Contact:
Company Secretary
Tel: 0207 216 6800
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.